Model ID | PRLR Density vs MCF7 | Drug Dosesa | ABBV-176 Efficacyb | ER/PR/HER2 BRCA Status |
---|---|---|---|---|
CTG-1124 | 0.15 | 0.2 | High (84%) | ER+/PR+ BRCA 1 def |
CTG-0012 | 0.75 | 0.5 | High (90%) | TNBC BRCA 1 def |
CTG-0869 | 0.8 | 0.5 | High (93%) | TNBC BRCA 1 mut |
CTG-0670 | 1.64 | 0.5 | High (91%) | TNBC BRCA 1 def, BRCA 2 mut |
CTG-0033c | 2.06 | 0.2 | High (79%) | HER2+ BRCA n.d. |
CTG-1171 | 0.42 | 0.2 | High (82%) | TNBC BRCA 1, 2 mut |
CTG-1019 | 0.37 | 0.2 | High (83%) | TNBC BRCA 1, 2 mut |
CTG-1242 | 3.83 | 0.2 | High (83%) | TNBC BRCA n.d. |
CTG-0052 | 0.46 | 0.2 | Moderate (59%) | TNBC BRCA wild type |
CTG-0017 | 0.27 | 0.2 | Moderate (62%) | TNBC BRCA 1, 2 mut |
CTG-1520 | 0.56 | 0.5 | Low (48%) | TNBC BRCA wild type |